Global GLP-1 for Weight Loss Market Growth 2026-2032
The global GLP-1 for Weight Loss market size is predicted to grow from US$ 4713 million in 2025 to US$ 17750 million in 2032; it is expected to grow at a CAGR of 21.3% from 2026 to 2032.
GLP-1, or glucagon-like peptide-1, is a naturally occurring hormone in the body that plays a role in glucose homeostasis and appetite regulation. In the context of weight loss, GLP-1 has gained attention due to its potential to influence body weight.
GLP-1-based medications, such as GLP-1 receptor agonists, are a class of drugs used primarily for the treatment of type 2 diabetes. However, they have also been found to have beneficial effects on body weight. These drugs mimic the action of GLP-1 in the body, leading to increased insulin secretion, decreased glucagon release, slowed gastric emptying, and a sense of fullness. These effects collectively contribute to improved blood sugar control and a reduction in appetite and food intake.
Expanding Indications: GLP-1 receptor agonists were primarily developed for the treatment of type 2 diabetes. However, there was growing interest in their potential application for weight management in individuals without diabetes. Some GLP-1 medications received regulatory approval for weight loss.
New Drug Development: Pharmaceutical companies were investing in the research and development of new GLP-1 receptor agonists with enhanced properties, including improved efficacy, longer duration of action, and better tolerability. These developments aimed to address various patient needs and preferences.
Combination Therapies: Researchers were exploring the use of GLP-1 medications in combination with other weight loss therapies, such as anti-obesity medications or lifestyle interventions. Combining different approaches could provide synergistic effects in promoting weight loss.
Increased Patient Awareness: As more research findings became available and regulatory approvals were granted for weight management, there was an increased awareness among healthcare professionals and patients regarding the potential benefits of GLP-1 receptor agonists for weight loss.
Market Competition: With the emergence of new medications and indications, the market for GLP-1-based therapies for weight loss was becoming more competitive. This competition could drive innovation and potentially lead to more accessible and diverse treatment options.
LP Information, Inc. (LPI) ' newest research report, the ?GLP-1 for Weight Loss Industry Forecast? looks at past sales and reviews total world GLP-1 for Weight Loss sales in 2025, providing a comprehensive analysis by region and market sector of projected GLP-1 for Weight Loss sales for 2026 through 2032. With GLP-1 for Weight Loss sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GLP-1 for Weight Loss industry.
This Insight Report provides a comprehensive analysis of the global GLP-1 for Weight Loss landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GLP-1 for Weight Loss portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global GLP-1 for Weight Loss market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GLP-1 for Weight Loss and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GLP-1 for Weight Loss.
This report presents a comprehensive overview, market shares, and growth opportunities of GLP-1 for Weight Loss market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
GLP-1, or glucagon-like peptide-1, is a naturally occurring hormone in the body that plays a role in glucose homeostasis and appetite regulation. In the context of weight loss, GLP-1 has gained attention due to its potential to influence body weight.
GLP-1-based medications, such as GLP-1 receptor agonists, are a class of drugs used primarily for the treatment of type 2 diabetes. However, they have also been found to have beneficial effects on body weight. These drugs mimic the action of GLP-1 in the body, leading to increased insulin secretion, decreased glucagon release, slowed gastric emptying, and a sense of fullness. These effects collectively contribute to improved blood sugar control and a reduction in appetite and food intake.
Expanding Indications: GLP-1 receptor agonists were primarily developed for the treatment of type 2 diabetes. However, there was growing interest in their potential application for weight management in individuals without diabetes. Some GLP-1 medications received regulatory approval for weight loss.
New Drug Development: Pharmaceutical companies were investing in the research and development of new GLP-1 receptor agonists with enhanced properties, including improved efficacy, longer duration of action, and better tolerability. These developments aimed to address various patient needs and preferences.
Combination Therapies: Researchers were exploring the use of GLP-1 medications in combination with other weight loss therapies, such as anti-obesity medications or lifestyle interventions. Combining different approaches could provide synergistic effects in promoting weight loss.
Increased Patient Awareness: As more research findings became available and regulatory approvals were granted for weight management, there was an increased awareness among healthcare professionals and patients regarding the potential benefits of GLP-1 receptor agonists for weight loss.
Market Competition: With the emergence of new medications and indications, the market for GLP-1-based therapies for weight loss was becoming more competitive. This competition could drive innovation and potentially lead to more accessible and diverse treatment options.
LP Information, Inc. (LPI) ' newest research report, the ?GLP-1 for Weight Loss Industry Forecast? looks at past sales and reviews total world GLP-1 for Weight Loss sales in 2025, providing a comprehensive analysis by region and market sector of projected GLP-1 for Weight Loss sales for 2026 through 2032. With GLP-1 for Weight Loss sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GLP-1 for Weight Loss industry.
This Insight Report provides a comprehensive analysis of the global GLP-1 for Weight Loss landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GLP-1 for Weight Loss portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global GLP-1 for Weight Loss market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GLP-1 for Weight Loss and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GLP-1 for Weight Loss.
This report presents a comprehensive overview, market shares, and growth opportunities of GLP-1 for Weight Loss market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Injection
- Oral Agent
- Woman
- Man
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novo Nordisk
- AstraZeneca
- Eli Lily
- GSK
- Sanofi
- Bristol-Myers Squibb
- Amylin
- What is the 10-year outlook for the global GLP-1 for Weight Loss market?
- What factors are driving GLP-1 for Weight Loss market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do GLP-1 for Weight Loss market opportunities vary by end market size?
- How does GLP-1 for Weight Loss break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GLP-1 for Weight Loss Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for GLP-1 for Weight Loss by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for GLP-1 for Weight Loss by Country/Region, 2021, 2025 & 2032
2.2 GLP-1 for Weight Loss Segment by Type
2.2.1 Injection
2.2.2 Oral Agent
2.2.3 GLP-1 for Weight Loss Sales by Type
2.2.3.1 Global GLP-1 for Weight Loss Sales Market Share by Type (2021-2026)
2.2.3.2 Global GLP-1 for Weight Loss Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global GLP-1 for Weight Loss Sale Price by Type (2021-2026)
2.3 GLP-1 for Weight Loss Segment by Application
2.3.1 Woman
2.3.2 Man
2.3.3 GLP-1 for Weight Loss Sales by Application
2.3.3.1 Global GLP-1 for Weight Loss Sale Market Share by Application (2021-2026)
2.3.3.2 Global GLP-1 for Weight Loss Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global GLP-1 for Weight Loss Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global GLP-1 for Weight Loss Breakdown Data by Company
3.1.1 Global GLP-1 for Weight Loss Annual Sales by Company (2021-2026)
3.1.2 Global GLP-1 for Weight Loss Sales Market Share by Company (2021-2026)
3.2 Global GLP-1 for Weight Loss Annual Revenue by Company (2021-2026)
3.2.1 Global GLP-1 for Weight Loss Revenue by Company (2021-2026)
3.2.2 Global GLP-1 for Weight Loss Revenue Market Share by Company (2021-2026)
3.3 Global GLP-1 for Weight Loss Sale Price by Company
3.4 Key Manufacturers GLP-1 for Weight Loss Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers GLP-1 for Weight Loss Product Location Distribution
3.4.2 Players GLP-1 for Weight Loss Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GLP-1 FOR WEIGHT LOSS BY GEOGRAPHIC REGION
4.1 World Historic GLP-1 for Weight Loss Market Size by Geographic Region (2021-2026)
4.1.1 Global GLP-1 for Weight Loss Annual Sales by Geographic Region (2021-2026)
4.1.2 Global GLP-1 for Weight Loss Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic GLP-1 for Weight Loss Market Size by Country/Region (2021-2026)
4.2.1 Global GLP-1 for Weight Loss Annual Sales by Country/Region (2021-2026)
4.2.2 Global GLP-1 for Weight Loss Annual Revenue by Country/Region (2021-2026)
4.3 Americas GLP-1 for Weight Loss Sales Growth
4.4 APAC GLP-1 for Weight Loss Sales Growth
4.5 Europe GLP-1 for Weight Loss Sales Growth
4.6 Middle East & Africa GLP-1 for Weight Loss Sales Growth
5 AMERICAS
5.1 Americas GLP-1 for Weight Loss Sales by Country
5.1.1 Americas GLP-1 for Weight Loss Sales by Country (2021-2026)
5.1.2 Americas GLP-1 for Weight Loss Revenue by Country (2021-2026)
5.2 Americas GLP-1 for Weight Loss Sales by Type (2021-2026)
5.3 Americas GLP-1 for Weight Loss Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GLP-1 for Weight Loss Sales by Region
6.1.1 APAC GLP-1 for Weight Loss Sales by Region (2021-2026)
6.1.2 APAC GLP-1 for Weight Loss Revenue by Region (2021-2026)
6.2 APAC GLP-1 for Weight Loss Sales by Type (2021-2026)
6.3 APAC GLP-1 for Weight Loss Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe GLP-1 for Weight Loss by Country
7.1.1 Europe GLP-1 for Weight Loss Sales by Country (2021-2026)
7.1.2 Europe GLP-1 for Weight Loss Revenue by Country (2021-2026)
7.2 Europe GLP-1 for Weight Loss Sales by Type (2021-2026)
7.3 Europe GLP-1 for Weight Loss Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GLP-1 for Weight Loss by Country
8.1.1 Middle East & Africa GLP-1 for Weight Loss Sales by Country (2021-2026)
8.1.2 Middle East & Africa GLP-1 for Weight Loss Revenue by Country (2021-2026)
8.2 Middle East & Africa GLP-1 for Weight Loss Sales by Type (2021-2026)
8.3 Middle East & Africa GLP-1 for Weight Loss Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GLP-1 for Weight Loss
10.3 Manufacturing Process Analysis of GLP-1 for Weight Loss
10.4 Industry Chain Structure of GLP-1 for Weight Loss
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 GLP-1 for Weight Loss Distributors
11.3 GLP-1 for Weight Loss Customer
12 WORLD FORECAST REVIEW FOR GLP-1 FOR WEIGHT LOSS BY GEOGRAPHIC REGION
12.1 Global GLP-1 for Weight Loss Market Size Forecast by Region
12.1.1 Global GLP-1 for Weight Loss Forecast by Region (2027-2032)
12.1.2 Global GLP-1 for Weight Loss Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global GLP-1 for Weight Loss Forecast by Type (2027-2032)
12.7 Global GLP-1 for Weight Loss Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk GLP-1 for Weight Loss Product Portfolios and Specifications
13.1.3 Novo Nordisk GLP-1 for Weight Loss Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca GLP-1 for Weight Loss Product Portfolios and Specifications
13.2.3 AstraZeneca GLP-1 for Weight Loss Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Eli Lily
13.3.1 Eli Lily Company Information
13.3.2 Eli Lily GLP-1 for Weight Loss Product Portfolios and Specifications
13.3.3 Eli Lily GLP-1 for Weight Loss Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Eli Lily Main Business Overview
13.3.5 Eli Lily Latest Developments
13.4 GSK
13.4.1 GSK Company Information
13.4.2 GSK GLP-1 for Weight Loss Product Portfolios and Specifications
13.4.3 GSK GLP-1 for Weight Loss Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 GSK Main Business Overview
13.4.5 GSK Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi GLP-1 for Weight Loss Product Portfolios and Specifications
13.5.3 Sanofi GLP-1 for Weight Loss Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Bristol-Myers Squibb
13.6.1 Bristol-Myers Squibb Company Information
13.6.2 Bristol-Myers Squibb GLP-1 for Weight Loss Product Portfolios and Specifications
13.6.3 Bristol-Myers Squibb GLP-1 for Weight Loss Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Bristol-Myers Squibb Main Business Overview
13.6.5 Bristol-Myers Squibb Latest Developments
13.7 Amylin
13.7.1 Amylin Company Information
13.7.2 Amylin GLP-1 for Weight Loss Product Portfolios and Specifications
13.7.3 Amylin GLP-1 for Weight Loss Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Amylin Main Business Overview
13.7.5 Amylin Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GLP-1 for Weight Loss Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for GLP-1 for Weight Loss by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for GLP-1 for Weight Loss by Country/Region, 2021, 2025 & 2032
2.2 GLP-1 for Weight Loss Segment by Type
2.2.1 Injection
2.2.2 Oral Agent
2.2.3 GLP-1 for Weight Loss Sales by Type
2.2.3.1 Global GLP-1 for Weight Loss Sales Market Share by Type (2021-2026)
2.2.3.2 Global GLP-1 for Weight Loss Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global GLP-1 for Weight Loss Sale Price by Type (2021-2026)
2.3 GLP-1 for Weight Loss Segment by Application
2.3.1 Woman
2.3.2 Man
2.3.3 GLP-1 for Weight Loss Sales by Application
2.3.3.1 Global GLP-1 for Weight Loss Sale Market Share by Application (2021-2026)
2.3.3.2 Global GLP-1 for Weight Loss Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global GLP-1 for Weight Loss Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global GLP-1 for Weight Loss Breakdown Data by Company
3.1.1 Global GLP-1 for Weight Loss Annual Sales by Company (2021-2026)
3.1.2 Global GLP-1 for Weight Loss Sales Market Share by Company (2021-2026)
3.2 Global GLP-1 for Weight Loss Annual Revenue by Company (2021-2026)
3.2.1 Global GLP-1 for Weight Loss Revenue by Company (2021-2026)
3.2.2 Global GLP-1 for Weight Loss Revenue Market Share by Company (2021-2026)
3.3 Global GLP-1 for Weight Loss Sale Price by Company
3.4 Key Manufacturers GLP-1 for Weight Loss Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers GLP-1 for Weight Loss Product Location Distribution
3.4.2 Players GLP-1 for Weight Loss Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GLP-1 FOR WEIGHT LOSS BY GEOGRAPHIC REGION
4.1 World Historic GLP-1 for Weight Loss Market Size by Geographic Region (2021-2026)
4.1.1 Global GLP-1 for Weight Loss Annual Sales by Geographic Region (2021-2026)
4.1.2 Global GLP-1 for Weight Loss Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic GLP-1 for Weight Loss Market Size by Country/Region (2021-2026)
4.2.1 Global GLP-1 for Weight Loss Annual Sales by Country/Region (2021-2026)
4.2.2 Global GLP-1 for Weight Loss Annual Revenue by Country/Region (2021-2026)
4.3 Americas GLP-1 for Weight Loss Sales Growth
4.4 APAC GLP-1 for Weight Loss Sales Growth
4.5 Europe GLP-1 for Weight Loss Sales Growth
4.6 Middle East & Africa GLP-1 for Weight Loss Sales Growth
5 AMERICAS
5.1 Americas GLP-1 for Weight Loss Sales by Country
5.1.1 Americas GLP-1 for Weight Loss Sales by Country (2021-2026)
5.1.2 Americas GLP-1 for Weight Loss Revenue by Country (2021-2026)
5.2 Americas GLP-1 for Weight Loss Sales by Type (2021-2026)
5.3 Americas GLP-1 for Weight Loss Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GLP-1 for Weight Loss Sales by Region
6.1.1 APAC GLP-1 for Weight Loss Sales by Region (2021-2026)
6.1.2 APAC GLP-1 for Weight Loss Revenue by Region (2021-2026)
6.2 APAC GLP-1 for Weight Loss Sales by Type (2021-2026)
6.3 APAC GLP-1 for Weight Loss Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe GLP-1 for Weight Loss by Country
7.1.1 Europe GLP-1 for Weight Loss Sales by Country (2021-2026)
7.1.2 Europe GLP-1 for Weight Loss Revenue by Country (2021-2026)
7.2 Europe GLP-1 for Weight Loss Sales by Type (2021-2026)
7.3 Europe GLP-1 for Weight Loss Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GLP-1 for Weight Loss by Country
8.1.1 Middle East & Africa GLP-1 for Weight Loss Sales by Country (2021-2026)
8.1.2 Middle East & Africa GLP-1 for Weight Loss Revenue by Country (2021-2026)
8.2 Middle East & Africa GLP-1 for Weight Loss Sales by Type (2021-2026)
8.3 Middle East & Africa GLP-1 for Weight Loss Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GLP-1 for Weight Loss
10.3 Manufacturing Process Analysis of GLP-1 for Weight Loss
10.4 Industry Chain Structure of GLP-1 for Weight Loss
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 GLP-1 for Weight Loss Distributors
11.3 GLP-1 for Weight Loss Customer
12 WORLD FORECAST REVIEW FOR GLP-1 FOR WEIGHT LOSS BY GEOGRAPHIC REGION
12.1 Global GLP-1 for Weight Loss Market Size Forecast by Region
12.1.1 Global GLP-1 for Weight Loss Forecast by Region (2027-2032)
12.1.2 Global GLP-1 for Weight Loss Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global GLP-1 for Weight Loss Forecast by Type (2027-2032)
12.7 Global GLP-1 for Weight Loss Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk GLP-1 for Weight Loss Product Portfolios and Specifications
13.1.3 Novo Nordisk GLP-1 for Weight Loss Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca GLP-1 for Weight Loss Product Portfolios and Specifications
13.2.3 AstraZeneca GLP-1 for Weight Loss Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Eli Lily
13.3.1 Eli Lily Company Information
13.3.2 Eli Lily GLP-1 for Weight Loss Product Portfolios and Specifications
13.3.3 Eli Lily GLP-1 for Weight Loss Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Eli Lily Main Business Overview
13.3.5 Eli Lily Latest Developments
13.4 GSK
13.4.1 GSK Company Information
13.4.2 GSK GLP-1 for Weight Loss Product Portfolios and Specifications
13.4.3 GSK GLP-1 for Weight Loss Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 GSK Main Business Overview
13.4.5 GSK Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi GLP-1 for Weight Loss Product Portfolios and Specifications
13.5.3 Sanofi GLP-1 for Weight Loss Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Bristol-Myers Squibb
13.6.1 Bristol-Myers Squibb Company Information
13.6.2 Bristol-Myers Squibb GLP-1 for Weight Loss Product Portfolios and Specifications
13.6.3 Bristol-Myers Squibb GLP-1 for Weight Loss Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Bristol-Myers Squibb Main Business Overview
13.6.5 Bristol-Myers Squibb Latest Developments
13.7 Amylin
13.7.1 Amylin Company Information
13.7.2 Amylin GLP-1 for Weight Loss Product Portfolios and Specifications
13.7.3 Amylin GLP-1 for Weight Loss Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Amylin Main Business Overview
13.7.5 Amylin Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. GLP-1 for Weight Loss Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. GLP-1 for Weight Loss Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Oral Agent
Table 5. Global GLP-1 for Weight Loss Sales by Type (2021-2026) & (Kg)
Table 6. Global GLP-1 for Weight Loss Sales Market Share by Type (2021-2026)
Table 7. Global GLP-1 for Weight Loss Revenue by Type (2021-2026) & ($ million)
Table 8. Global GLP-1 for Weight Loss Revenue Market Share by Type (2021-2026)
Table 9. Global GLP-1 for Weight Loss Sale Price by Type (2021-2026) & (US$/Mg)
Table 10. Global GLP-1 for Weight Loss Sale by Application (2021-2026) & (Kg)
Table 11. Global GLP-1 for Weight Loss Sale Market Share by Application (2021-2026)
Table 12. Global GLP-1 for Weight Loss Revenue by Application (2021-2026) & ($ million)
Table 13. Global GLP-1 for Weight Loss Revenue Market Share by Application (2021-2026)
Table 14. Global GLP-1 for Weight Loss Sale Price by Application (2021-2026) & (US$/Mg)
Table 15. Global GLP-1 for Weight Loss Sales by Company (2021-2026) & (Kg)
Table 16. Global GLP-1 for Weight Loss Sales Market Share by Company (2021-2026)
Table 17. Global GLP-1 for Weight Loss Revenue by Company (2021-2026) & ($ millions)
Table 18. Global GLP-1 for Weight Loss Revenue Market Share by Company (2021-2026)
Table 19. Global GLP-1 for Weight Loss Sale Price by Company (2021-2026) & (US$/Mg)
Table 20. Key Manufacturers GLP-1 for Weight Loss Producing Area Distribution and Sales Area
Table 21. Players GLP-1 for Weight Loss Products Offered
Table 22. GLP-1 for Weight Loss Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global GLP-1 for Weight Loss Sales by Geographic Region (2021-2026) & (Kg)
Table 26. Global GLP-1 for Weight Loss Sales Market Share Geographic Region (2021-2026)
Table 27. Global GLP-1 for Weight Loss Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global GLP-1 for Weight Loss Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global GLP-1 for Weight Loss Sales by Country/Region (2021-2026) & (Kg)
Table 30. Global GLP-1 for Weight Loss Sales Market Share by Country/Region (2021-2026)
Table 31. Global GLP-1 for Weight Loss Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global GLP-1 for Weight Loss Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas GLP-1 for Weight Loss Sales by Country (2021-2026) & (Kg)
Table 34. Americas GLP-1 for Weight Loss Sales Market Share by Country (2021-2026)
Table 35. Americas GLP-1 for Weight Loss Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas GLP-1 for Weight Loss Sales by Type (2021-2026) & (Kg)
Table 37. Americas GLP-1 for Weight Loss Sales by Application (2021-2026) & (Kg)
Table 38. APAC GLP-1 for Weight Loss Sales by Region (2021-2026) & (Kg)
Table 39. APAC GLP-1 for Weight Loss Sales Market Share by Region (2021-2026)
Table 40. APAC GLP-1 for Weight Loss Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC GLP-1 for Weight Loss Sales by Type (2021-2026) & (Kg)
Table 42. APAC GLP-1 for Weight Loss Sales by Application (2021-2026) & (Kg)
Table 43. Europe GLP-1 for Weight Loss Sales by Country (2021-2026) & (Kg)
Table 44. Europe GLP-1 for Weight Loss Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe GLP-1 for Weight Loss Sales by Type (2021-2026) & (Kg)
Table 46. Europe GLP-1 for Weight Loss Sales by Application (2021-2026) & (Kg)
Table 47. Middle East & Africa GLP-1 for Weight Loss Sales by Country (2021-2026) & (Kg)
Table 48. Middle East & Africa GLP-1 for Weight Loss Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa GLP-1 for Weight Loss Sales by Type (2021-2026) & (Kg)
Table 50. Middle East & Africa GLP-1 for Weight Loss Sales by Application (2021-2026) & (Kg)
Table 51. Key Market Drivers & Growth Opportunities of GLP-1 for Weight Loss
Table 52. Key Market Challenges & Risks of GLP-1 for Weight Loss
Table 53. Key Industry Trends of GLP-1 for Weight Loss
Table 54. GLP-1 for Weight Loss Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. GLP-1 for Weight Loss Distributors List
Table 57. GLP-1 for Weight Loss Customer List
Table 58. Global GLP-1 for Weight Loss Sales Forecast by Region (2027-2032) & (Kg)
Table 59. Global GLP-1 for Weight Loss Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas GLP-1 for Weight Loss Sales Forecast by Country (2027-2032) & (Kg)
Table 61. Americas GLP-1 for Weight Loss Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC GLP-1 for Weight Loss Sales Forecast by Region (2027-2032) & (Kg)
Table 63. APAC GLP-1 for Weight Loss Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe GLP-1 for Weight Loss Sales Forecast by Country (2027-2032) & (Kg)
Table 65. Europe GLP-1 for Weight Loss Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa GLP-1 for Weight Loss Sales Forecast by Country (2027-2032) & (Kg)
Table 67. Middle East & Africa GLP-1 for Weight Loss Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global GLP-1 for Weight Loss Sales Forecast by Type (2027-2032) & (Kg)
Table 69. Global GLP-1 for Weight Loss Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global GLP-1 for Weight Loss Sales Forecast by Application (2027-2032) & (Kg)
Table 71. Global GLP-1 for Weight Loss Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Novo Nordisk Basic Information, GLP-1 for Weight Loss Manufacturing Base, Sales Area and Its Competitors
Table 73. Novo Nordisk GLP-1 for Weight Loss Product Portfolios and Specifications
Table 74. Novo Nordisk GLP-1 for Weight Loss Sales (Kg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2021-2026)
Table 75. Novo Nordisk Main Business
Table 76. Novo Nordisk Latest Developments
Table 77. AstraZeneca Basic Information, GLP-1 for Weight Loss Manufacturing Base, Sales Area and Its Competitors
Table 78. AstraZeneca GLP-1 for Weight Loss Product Portfolios and Specifications
Table 79. AstraZeneca GLP-1 for Weight Loss Sales (Kg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2021-2026)
Table 80. AstraZeneca Main Business
Table 81. AstraZeneca Latest Developments
Table 82. Eli Lily Basic Information, GLP-1 for Weight Loss Manufacturing Base, Sales Area and Its Competitors
Table 83. Eli Lily GLP-1 for Weight Loss Product Portfolios and Specifications
Table 84. Eli Lily GLP-1 for Weight Loss Sales (Kg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2021-2026)
Table 85. Eli Lily Main Business
Table 86. Eli Lily Latest Developments
Table 87. GSK Basic Information, GLP-1 for Weight Loss Manufacturing Base, Sales Area and Its Competitors
Table 88. GSK GLP-1 for Weight Loss Product Portfolios and Specifications
Table 89. GSK GLP-1 for Weight Loss Sales (Kg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2021-2026)
Table 90. GSK Main Business
Table 91. GSK Latest Developments
Table 92. Sanofi Basic Information, GLP-1 for Weight Loss Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi GLP-1 for Weight Loss Product Portfolios and Specifications
Table 94. Sanofi GLP-1 for Weight Loss Sales (Kg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2021-2026)
Table 95. Sanofi Main Business
Table 96. Sanofi Latest Developments
Table 97. Bristol-Myers Squibb Basic Information, GLP-1 for Weight Loss Manufacturing Base, Sales Area and Its Competitors
Table 98. Bristol-Myers Squibb GLP-1 for Weight Loss Product Portfolios and Specifications
Table 99. Bristol-Myers Squibb GLP-1 for Weight Loss Sales (Kg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2021-2026)
Table 100. Bristol-Myers Squibb Main Business
Table 101. Bristol-Myers Squibb Latest Developments
Table 102. Amylin Basic Information, GLP-1 for Weight Loss Manufacturing Base, Sales Area and Its Competitors
Table 103. Amylin GLP-1 for Weight Loss Product Portfolios and Specifications
Table 104. Amylin GLP-1 for Weight Loss Sales (Kg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2021-2026)
Table 105. Amylin Main Business
Table 106. Amylin Latest Developments
Table 1. GLP-1 for Weight Loss Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. GLP-1 for Weight Loss Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Oral Agent
Table 5. Global GLP-1 for Weight Loss Sales by Type (2021-2026) & (Kg)
Table 6. Global GLP-1 for Weight Loss Sales Market Share by Type (2021-2026)
Table 7. Global GLP-1 for Weight Loss Revenue by Type (2021-2026) & ($ million)
Table 8. Global GLP-1 for Weight Loss Revenue Market Share by Type (2021-2026)
Table 9. Global GLP-1 for Weight Loss Sale Price by Type (2021-2026) & (US$/Mg)
Table 10. Global GLP-1 for Weight Loss Sale by Application (2021-2026) & (Kg)
Table 11. Global GLP-1 for Weight Loss Sale Market Share by Application (2021-2026)
Table 12. Global GLP-1 for Weight Loss Revenue by Application (2021-2026) & ($ million)
Table 13. Global GLP-1 for Weight Loss Revenue Market Share by Application (2021-2026)
Table 14. Global GLP-1 for Weight Loss Sale Price by Application (2021-2026) & (US$/Mg)
Table 15. Global GLP-1 for Weight Loss Sales by Company (2021-2026) & (Kg)
Table 16. Global GLP-1 for Weight Loss Sales Market Share by Company (2021-2026)
Table 17. Global GLP-1 for Weight Loss Revenue by Company (2021-2026) & ($ millions)
Table 18. Global GLP-1 for Weight Loss Revenue Market Share by Company (2021-2026)
Table 19. Global GLP-1 for Weight Loss Sale Price by Company (2021-2026) & (US$/Mg)
Table 20. Key Manufacturers GLP-1 for Weight Loss Producing Area Distribution and Sales Area
Table 21. Players GLP-1 for Weight Loss Products Offered
Table 22. GLP-1 for Weight Loss Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global GLP-1 for Weight Loss Sales by Geographic Region (2021-2026) & (Kg)
Table 26. Global GLP-1 for Weight Loss Sales Market Share Geographic Region (2021-2026)
Table 27. Global GLP-1 for Weight Loss Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global GLP-1 for Weight Loss Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global GLP-1 for Weight Loss Sales by Country/Region (2021-2026) & (Kg)
Table 30. Global GLP-1 for Weight Loss Sales Market Share by Country/Region (2021-2026)
Table 31. Global GLP-1 for Weight Loss Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global GLP-1 for Weight Loss Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas GLP-1 for Weight Loss Sales by Country (2021-2026) & (Kg)
Table 34. Americas GLP-1 for Weight Loss Sales Market Share by Country (2021-2026)
Table 35. Americas GLP-1 for Weight Loss Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas GLP-1 for Weight Loss Sales by Type (2021-2026) & (Kg)
Table 37. Americas GLP-1 for Weight Loss Sales by Application (2021-2026) & (Kg)
Table 38. APAC GLP-1 for Weight Loss Sales by Region (2021-2026) & (Kg)
Table 39. APAC GLP-1 for Weight Loss Sales Market Share by Region (2021-2026)
Table 40. APAC GLP-1 for Weight Loss Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC GLP-1 for Weight Loss Sales by Type (2021-2026) & (Kg)
Table 42. APAC GLP-1 for Weight Loss Sales by Application (2021-2026) & (Kg)
Table 43. Europe GLP-1 for Weight Loss Sales by Country (2021-2026) & (Kg)
Table 44. Europe GLP-1 for Weight Loss Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe GLP-1 for Weight Loss Sales by Type (2021-2026) & (Kg)
Table 46. Europe GLP-1 for Weight Loss Sales by Application (2021-2026) & (Kg)
Table 47. Middle East & Africa GLP-1 for Weight Loss Sales by Country (2021-2026) & (Kg)
Table 48. Middle East & Africa GLP-1 for Weight Loss Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa GLP-1 for Weight Loss Sales by Type (2021-2026) & (Kg)
Table 50. Middle East & Africa GLP-1 for Weight Loss Sales by Application (2021-2026) & (Kg)
Table 51. Key Market Drivers & Growth Opportunities of GLP-1 for Weight Loss
Table 52. Key Market Challenges & Risks of GLP-1 for Weight Loss
Table 53. Key Industry Trends of GLP-1 for Weight Loss
Table 54. GLP-1 for Weight Loss Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. GLP-1 for Weight Loss Distributors List
Table 57. GLP-1 for Weight Loss Customer List
Table 58. Global GLP-1 for Weight Loss Sales Forecast by Region (2027-2032) & (Kg)
Table 59. Global GLP-1 for Weight Loss Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas GLP-1 for Weight Loss Sales Forecast by Country (2027-2032) & (Kg)
Table 61. Americas GLP-1 for Weight Loss Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC GLP-1 for Weight Loss Sales Forecast by Region (2027-2032) & (Kg)
Table 63. APAC GLP-1 for Weight Loss Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe GLP-1 for Weight Loss Sales Forecast by Country (2027-2032) & (Kg)
Table 65. Europe GLP-1 for Weight Loss Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa GLP-1 for Weight Loss Sales Forecast by Country (2027-2032) & (Kg)
Table 67. Middle East & Africa GLP-1 for Weight Loss Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global GLP-1 for Weight Loss Sales Forecast by Type (2027-2032) & (Kg)
Table 69. Global GLP-1 for Weight Loss Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global GLP-1 for Weight Loss Sales Forecast by Application (2027-2032) & (Kg)
Table 71. Global GLP-1 for Weight Loss Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Novo Nordisk Basic Information, GLP-1 for Weight Loss Manufacturing Base, Sales Area and Its Competitors
Table 73. Novo Nordisk GLP-1 for Weight Loss Product Portfolios and Specifications
Table 74. Novo Nordisk GLP-1 for Weight Loss Sales (Kg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2021-2026)
Table 75. Novo Nordisk Main Business
Table 76. Novo Nordisk Latest Developments
Table 77. AstraZeneca Basic Information, GLP-1 for Weight Loss Manufacturing Base, Sales Area and Its Competitors
Table 78. AstraZeneca GLP-1 for Weight Loss Product Portfolios and Specifications
Table 79. AstraZeneca GLP-1 for Weight Loss Sales (Kg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2021-2026)
Table 80. AstraZeneca Main Business
Table 81. AstraZeneca Latest Developments
Table 82. Eli Lily Basic Information, GLP-1 for Weight Loss Manufacturing Base, Sales Area and Its Competitors
Table 83. Eli Lily GLP-1 for Weight Loss Product Portfolios and Specifications
Table 84. Eli Lily GLP-1 for Weight Loss Sales (Kg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2021-2026)
Table 85. Eli Lily Main Business
Table 86. Eli Lily Latest Developments
Table 87. GSK Basic Information, GLP-1 for Weight Loss Manufacturing Base, Sales Area and Its Competitors
Table 88. GSK GLP-1 for Weight Loss Product Portfolios and Specifications
Table 89. GSK GLP-1 for Weight Loss Sales (Kg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2021-2026)
Table 90. GSK Main Business
Table 91. GSK Latest Developments
Table 92. Sanofi Basic Information, GLP-1 for Weight Loss Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi GLP-1 for Weight Loss Product Portfolios and Specifications
Table 94. Sanofi GLP-1 for Weight Loss Sales (Kg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2021-2026)
Table 95. Sanofi Main Business
Table 96. Sanofi Latest Developments
Table 97. Bristol-Myers Squibb Basic Information, GLP-1 for Weight Loss Manufacturing Base, Sales Area and Its Competitors
Table 98. Bristol-Myers Squibb GLP-1 for Weight Loss Product Portfolios and Specifications
Table 99. Bristol-Myers Squibb GLP-1 for Weight Loss Sales (Kg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2021-2026)
Table 100. Bristol-Myers Squibb Main Business
Table 101. Bristol-Myers Squibb Latest Developments
Table 102. Amylin Basic Information, GLP-1 for Weight Loss Manufacturing Base, Sales Area and Its Competitors
Table 103. Amylin GLP-1 for Weight Loss Product Portfolios and Specifications
Table 104. Amylin GLP-1 for Weight Loss Sales (Kg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2021-2026)
Table 105. Amylin Main Business
Table 106. Amylin Latest Developments
LIST OF FIGURES
Figure 1. Picture of GLP-1 for Weight Loss
Figure 2. GLP-1 for Weight Loss Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GLP-1 for Weight Loss Sales Growth Rate 2021-2032 (Kg)
Figure 7. Global GLP-1 for Weight Loss Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. GLP-1 for Weight Loss Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. GLP-1 for Weight Loss Sales Market Share by Country/Region (2025)
Figure 10. GLP-1 for Weight Loss Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Injection
Figure 12. Product Picture of Oral Agent
Figure 13. Global GLP-1 for Weight Loss Sales Market Share by Type in 2026
Figure 14. Global GLP-1 for Weight Loss Revenue Market Share by Type (2021-2026)
Figure 15. GLP-1 for Weight Loss Consumed in Woman
Figure 16. Global GLP-1 for Weight Loss Market: Woman (2021-2026) & (Kg)
Figure 17. GLP-1 for Weight Loss Consumed in Man
Figure 18. Global GLP-1 for Weight Loss Market: Man (2021-2026) & (Kg)
Figure 19. Global GLP-1 for Weight Loss Sale Market Share by Application (2025)
Figure 20. Global GLP-1 for Weight Loss Revenue Market Share by Application in 2026
Figure 21. GLP-1 for Weight Loss Sales by Company in 2026 (Kg)
Figure 22. Global GLP-1 for Weight Loss Sales Market Share by Company in 2026
Figure 23. GLP-1 for Weight Loss Revenue by Company in 2026 ($ millions)
Figure 24. Global GLP-1 for Weight Loss Revenue Market Share by Company in 2026
Figure 25. Global GLP-1 for Weight Loss Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global GLP-1 for Weight Loss Revenue Market Share by Geographic Region in 2026
Figure 27. Americas GLP-1 for Weight Loss Sales 2021-2026 (Kg)
Figure 28. Americas GLP-1 for Weight Loss Revenue 2021-2026 ($ millions)
Figure 29. APAC GLP-1 for Weight Loss Sales 2021-2026 (Kg)
Figure 30. APAC GLP-1 for Weight Loss Revenue 2021-2026 ($ millions)
Figure 31. Europe GLP-1 for Weight Loss Sales 2021-2026 (Kg)
Figure 32. Europe GLP-1 for Weight Loss Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa GLP-1 for Weight Loss Sales 2021-2026 (Kg)
Figure 34. Middle East & Africa GLP-1 for Weight Loss Revenue 2021-2026 ($ millions)
Figure 35. Americas GLP-1 for Weight Loss Sales Market Share by Country in 2026
Figure 36. Americas GLP-1 for Weight Loss Revenue Market Share by Country (2021-2026)
Figure 37. Americas GLP-1 for Weight Loss Sales Market Share by Type (2021-2026)
Figure 38. Americas GLP-1 for Weight Loss Sales Market Share by Application (2021-2026)
Figure 39. United States GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC GLP-1 for Weight Loss Sales Market Share by Region in 2026
Figure 44. APAC GLP-1 for Weight Loss Revenue Market Share by Region (2021-2026)
Figure 45. APAC GLP-1 for Weight Loss Sales Market Share by Type (2021-2026)
Figure 46. APAC GLP-1 for Weight Loss Sales Market Share by Application (2021-2026)
Figure 47. China GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 51. India GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe GLP-1 for Weight Loss Sales Market Share by Country in 2026
Figure 55. Europe GLP-1 for Weight Loss Revenue Market Share by Country (2021-2026)
Figure 56. Europe GLP-1 for Weight Loss Sales Market Share by Type (2021-2026)
Figure 57. Europe GLP-1 for Weight Loss Sales Market Share by Application (2021-2026)
Figure 58. Germany GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 59. France GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 60. UK GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa GLP-1 for Weight Loss Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa GLP-1 for Weight Loss Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa GLP-1 for Weight Loss Sales Market Share by Application (2021-2026)
Figure 66. Egypt GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of GLP-1 for Weight Loss in 2026
Figure 72. Manufacturing Process Analysis of GLP-1 for Weight Loss
Figure 73. Industry Chain Structure of GLP-1 for Weight Loss
Figure 74. Channels of Distribution
Figure 75. Global GLP-1 for Weight Loss Sales Market Forecast by Region (2027-2032)
Figure 76. Global GLP-1 for Weight Loss Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global GLP-1 for Weight Loss Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global GLP-1 for Weight Loss Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global GLP-1 for Weight Loss Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global GLP-1 for Weight Loss Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of GLP-1 for Weight Loss
Figure 2. GLP-1 for Weight Loss Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GLP-1 for Weight Loss Sales Growth Rate 2021-2032 (Kg)
Figure 7. Global GLP-1 for Weight Loss Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. GLP-1 for Weight Loss Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. GLP-1 for Weight Loss Sales Market Share by Country/Region (2025)
Figure 10. GLP-1 for Weight Loss Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Injection
Figure 12. Product Picture of Oral Agent
Figure 13. Global GLP-1 for Weight Loss Sales Market Share by Type in 2026
Figure 14. Global GLP-1 for Weight Loss Revenue Market Share by Type (2021-2026)
Figure 15. GLP-1 for Weight Loss Consumed in Woman
Figure 16. Global GLP-1 for Weight Loss Market: Woman (2021-2026) & (Kg)
Figure 17. GLP-1 for Weight Loss Consumed in Man
Figure 18. Global GLP-1 for Weight Loss Market: Man (2021-2026) & (Kg)
Figure 19. Global GLP-1 for Weight Loss Sale Market Share by Application (2025)
Figure 20. Global GLP-1 for Weight Loss Revenue Market Share by Application in 2026
Figure 21. GLP-1 for Weight Loss Sales by Company in 2026 (Kg)
Figure 22. Global GLP-1 for Weight Loss Sales Market Share by Company in 2026
Figure 23. GLP-1 for Weight Loss Revenue by Company in 2026 ($ millions)
Figure 24. Global GLP-1 for Weight Loss Revenue Market Share by Company in 2026
Figure 25. Global GLP-1 for Weight Loss Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global GLP-1 for Weight Loss Revenue Market Share by Geographic Region in 2026
Figure 27. Americas GLP-1 for Weight Loss Sales 2021-2026 (Kg)
Figure 28. Americas GLP-1 for Weight Loss Revenue 2021-2026 ($ millions)
Figure 29. APAC GLP-1 for Weight Loss Sales 2021-2026 (Kg)
Figure 30. APAC GLP-1 for Weight Loss Revenue 2021-2026 ($ millions)
Figure 31. Europe GLP-1 for Weight Loss Sales 2021-2026 (Kg)
Figure 32. Europe GLP-1 for Weight Loss Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa GLP-1 for Weight Loss Sales 2021-2026 (Kg)
Figure 34. Middle East & Africa GLP-1 for Weight Loss Revenue 2021-2026 ($ millions)
Figure 35. Americas GLP-1 for Weight Loss Sales Market Share by Country in 2026
Figure 36. Americas GLP-1 for Weight Loss Revenue Market Share by Country (2021-2026)
Figure 37. Americas GLP-1 for Weight Loss Sales Market Share by Type (2021-2026)
Figure 38. Americas GLP-1 for Weight Loss Sales Market Share by Application (2021-2026)
Figure 39. United States GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC GLP-1 for Weight Loss Sales Market Share by Region in 2026
Figure 44. APAC GLP-1 for Weight Loss Revenue Market Share by Region (2021-2026)
Figure 45. APAC GLP-1 for Weight Loss Sales Market Share by Type (2021-2026)
Figure 46. APAC GLP-1 for Weight Loss Sales Market Share by Application (2021-2026)
Figure 47. China GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 51. India GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe GLP-1 for Weight Loss Sales Market Share by Country in 2026
Figure 55. Europe GLP-1 for Weight Loss Revenue Market Share by Country (2021-2026)
Figure 56. Europe GLP-1 for Weight Loss Sales Market Share by Type (2021-2026)
Figure 57. Europe GLP-1 for Weight Loss Sales Market Share by Application (2021-2026)
Figure 58. Germany GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 59. France GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 60. UK GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa GLP-1 for Weight Loss Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa GLP-1 for Weight Loss Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa GLP-1 for Weight Loss Sales Market Share by Application (2021-2026)
Figure 66. Egypt GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries GLP-1 for Weight Loss Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of GLP-1 for Weight Loss in 2026
Figure 72. Manufacturing Process Analysis of GLP-1 for Weight Loss
Figure 73. Industry Chain Structure of GLP-1 for Weight Loss
Figure 74. Channels of Distribution
Figure 75. Global GLP-1 for Weight Loss Sales Market Forecast by Region (2027-2032)
Figure 76. Global GLP-1 for Weight Loss Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global GLP-1 for Weight Loss Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global GLP-1 for Weight Loss Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global GLP-1 for Weight Loss Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global GLP-1 for Weight Loss Revenue Market Share Forecast by Application (2027-2032)
